O24 The impact of early referral and lowering clinical thresholds of biologic access on the disease course and costs in RA: results from the SiMSK study

Alan R. Roach; Elaine M. Dennison; Kimme L. Hyrich; Alex J. Macgregor

doi:10.1093/rheumatology/kez105.023

O24 The impact of early referral and lowering clinical thresholds of biologic access on the disease course and costs in RA: results from the SiMSK study

Alan R. Roach, Elaine M. Dennison, Kimme L. Hyrich, Alex J. Macgregor

Research output: Contribution to journal › Abstract › peer-review

Original language	English
Journal	Rheumatology
Volume	58
Issue number	Supplement_3
DOIs	https://doi.org/10.1093/rheumatology/kez105.023
Publication status	Published - 12 Apr 2019

Access to Document

10.1093/rheumatology/kez105.023Licence: Unspecified

Cite this

@article{b6fe5b20d88c40428578b3c67c6ee392,

title = "O24 The impact of early referral and lowering clinical thresholds of biologic access on the disease course and costs in RA: results from the SiMSK study",

author = "Roach, {Alan R.} and Dennison, {Elaine M.} and Hyrich, {Kimme L.} and Macgregor, {Alex J.}",

year = "2019",

month = apr,

day = "12",

doi = "10.1093/rheumatology/kez105.023",

language = "English",

volume = "58",

journal = "Rheumatology",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "Supplement_3",

}

TY - JOUR

T1 - O24 The impact of early referral and lowering clinical thresholds of biologic access on the disease course and costs in RA: results from the SiMSK study

AU - Roach, Alan R.

AU - Dennison, Elaine M.

AU - Hyrich, Kimme L.

AU - Macgregor, Alex J.

PY - 2019/4/12

Y1 - 2019/4/12

U2 - 10.1093/rheumatology/kez105.023

DO - 10.1093/rheumatology/kez105.023

M3 - Abstract

VL - 58

JO - Rheumatology

JF - Rheumatology

SN - 1462-0324

IS - Supplement_3

ER -